TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05876156

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual Reality Physical Therapy
Description: Participants are allowed to freely choose one game from the game list. Participant will be asked to wear a validated activity tracker - ActiGraph. Baseline heart rate will be collected for 1 minute. Participants will be wearing the ActiGraph during Physical Therapy session. Participants receiving VR intervention will be instructed to wear an Oculus Quest 2 headset (Meta, Inc., Menlo Park, CA) and participate in VR applications under the supervision of the physical therapist.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual Reality Physical Therapy
Description: Participants are allowed to freely choose one game from the game list. Participant will be asked to wear a validated activity tracker - ActiGraph. Baseline heart rate will be collected for 1 minute. Participants will be wearing the ActiGraph during Physical Therapy session. Participants receiving VR intervention will be instructed to wear an Oculus Quest 2 headset (Meta, Inc., Menlo Park, CA) and participate in VR applications under the supervision of the physical therapist.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Traditional Physical Therapy
Description: Participants will receive traditional Physical Therapy sessions (standard care) under the supervision of the accredited physical therapist. Participants will be wearing the Actigraph during Physical Therapy session. Participants will perform regular physical exercise, such as 20 minutes walking or biking on a stationary bike, under the supervision of a physical therapist.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Traditional Physical Therapy
Description: Participants will receive traditional Physical Therapy sessions (standard care) under the supervision of the accredited physical therapist. Participants will be wearing the Actigraph during Physical Therapy session. Participants will perform regular physical exercise, such as 20 minutes walking or biking on a stationary bike, under the supervision of a physical therapist.
Study: NCT05506943

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CTX-009
Description: IV infusion on day 1 and 14 of every 28 day cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: IV infusion on day 1, 8, and 15 of every 28 day cycle

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paclitaxel
Description: IV infusion on day 1, 8, and 15 of every 28 day cycle
Study: NCT06553521

Intervention type: OTHER
Group type: OTHER
Intervention: MyHEARTSMAP Youth Self-assessment Tool (At Admission)
Description: MyHEARTSMAP is a validated self-assessment tool for pediatric populations, demonstrating high sensitivity and specificity for identifying psychosocial concerns. Adapted from HEARTSMAP, it allows self- and proxy-reporting across 10 well-being domains, providing personalized recommendations. Currently, the clinician-reported HEARTSMAP is the standard of care at BC Children's Hospital ED for the initial assessment of youth with primary psychiatric concerns
Study: NCT05968833

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: iParent2Parent Program
Description: iParent2Parent is an online peer support mentorship program that is based on the iPeer2Peer online peer support mentorship program, which has been established in multiple chronic disease populations as a self-management intervention, including in chronic pain and juvenile idiopathic arthritis populations. The iParent2Parent program connect parents one-to-one with other parents of pediatric kidney transplant recipients who are trained to offer vital peer support and mentorship.
Study: NCT06318624

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mobilisation with Movement and Taping
Description: For MWM for the talocrural joint, the hemiparetic side of the participant is positioned in a standing position on a stool. A non-elastic belt is passed behind the patient's distal tibia and secured around the therapist's pelvis. The patient is asked to perform active knee flexion and ankle dorsiflexion with weight on the hemiparetic side. Meanwhile, the therapist performs forward sliding of the tibia with the help of the belt. For 10 seconds active and painless sliding takes place and then return to the starting position. This application is applied as 10 repetitions, 6 sets, and 1 minute rest between sets. Following the MWM application, Mulligan talus stabilization taping is performed. For this taping, the participants' ankles are placed on a stool at a height of 30 cm and their feet are placed in the dorsiflexion position. The therapist starts taping from the plantar surface of the calcaneus using rigid tape and will wrap and stabilize the talus.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: During joint mobilization with movement, the therapist will stabilize the ankle while performing knee flexion and ankle dorsiflexion by actively moving the center of mass to the affected side, but the shear force required to slide the tibia forward with the belt will not be given. Placebo taping following the application will be applied in such a way that there is no stabilization effect without tension between the same start and end points.
Study: NCT06553677

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Tunneled coronal advanced flap with connective tissue graft
Description: Tunneled coronal advanced flap with connective tissue graft to treat isolated RT2 gingival recession sites.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Coronally advanced flap with connective tissue graft
Description: Coronally advanced flap with connective tissue graft to treat isolated RT2 gingival recession sites
Study: NCT05958095

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MamaLift Plus
Description: MamaLift Plus is a digital therapeutic designed to augment usual care and support the treatment of mild-to-moderate postpartum depression (PPD). This mobile-based intervention is grounded on principles of Cognitive Behavioral Therapy (CBT) and Interpersonal Therapy (IPT) and includes key content areas for the treatment management of PPD. It also includes recent developments in acceptance and commitment-based therapies, specifically for the perinatal context.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Digital Sham App
Description: The digital sham app delivers content, tips, and suggestion for general wellbeing support.
Study: NCT06167499

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diabetes Therapeutic Education conducted by nurses
Description: Individual consultations with the therapeutic education IDE, who will help the patient to achieve the therapeutic objectives set before the medical consultation.~Once the objectives have been set, the IDE will set up individual workshops and subsequently assess the patient's learning and its impact on his or her care. These workshops can include equipment demonstrations and practical exercises, explanations of treatment adaptation protocols, and dietary or sexual advice.
Study: NCT05691634

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: MRI
Description: Patient with a tatoo will perform an MRI. The possible symptoms during the MRI or after MRI will then be described (duration, type,...).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Likert scale questionnaire
Description: The patient will appreciate his feeling after MRI on a Likert scale (from 1 to 5)
Study: NCT05201274

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Baduanjin sequential therapy
Description: A detailed description of a standardized Baduanjin exercise protocol complied with the Health Qigong Baduanjin Standard enacted by the General Administration of Sports in 2003.
Study: NCT05850091

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rosuvastatin
Description: Pharmacotherapy for reduction in LDL cholesterol level

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rosuvastatin
Description: Pharmacotherapy for reduction in LDL cholesterol level

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Colchicine
Description: Pharmacotherapy for inflammation inhibition

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Colchicine
Description: Pharmacotherapy for inflammation inhibition

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Capsule with sugar pill that mimics active study drugs

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Capsule with sugar pill that mimics active study drugs

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Capsule with sugar pill that mimics active study drugs
Study: NCT05201274

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Aerobic exercise
Description: Participants allocated to the usual exercise control group receive a closely supervised, group-format aerobic exercise program located at home or cardiac rehabilitation centre lasting 3 months. The program is consistent with the current recommended guidelines of moderate-intensity exercises for MI.
Study: NCT05573035

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LYL845
Description: LYL845 is an autologous tumor infiltrating lymphocyte (TIL) enhanced via Epi-R, a proprietary epigenetic reprogramming technology
Study: NCT05272046

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Per-oral Endoscopic Myotomy
Description: Therapeutic endoscopy procedure by means of electrocautery surgical tools for treatment of various esophageal conditions such as achalasia or spastic esophageal disorders.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Per-oral Endoscopic Myotomy
Description: Therapeutic endoscopy procedure by means of electrocautery surgical tools for treatment of various esophageal conditions such as achalasia or spastic esophageal disorders.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Speedboat (Bipolar electrocautery knife)
Description: Use of Creo Medical's Speedboat RS2 knife and generator in performing the POEM procedure for patients presenting with an esophageal motility disorder.
Study: NCT04821336

Intervention type: OTHER
Intervention: Metabolites dosage
Description: On samples investigators will quantify cholesterol metabolite and dendrogenin A (DDA) and 6-oxo-cholestane-3β,5α-diol (ou OCDO) metabolites in malignant tissue sample on one hand, and in sane samples on other hand.~The investigators will compare the rate of deregulation between sane and malignant ones.
Study: NCT05664100

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FX-345
Description: Single intratympanic injection of FX-345

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FX-345
Description: Single intratympanic injection of FX-345

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Single intratympanic injection of placebo

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Single intratympanic injection of placebo
Study: NCT05429424

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Verum acupuncture group
Description: The acupuncturist disinfected the skin of the selected acupoints with alcohol, then vertically penetrated the skin with disposable stainless-steel needles (size, brand, Taiwan) to the depth predetermined for each point (between 8-25 mm, depending on the location of the acupoint) and achieved a deqi response, often described as a pressure, fullness, or achiness feeling around the acupoints.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham control group I
Description: The needle does not penetrate the skin and retract in the handle while the acupuncturist needling into the skin. The participants easily believe their intervention owing to the sensation of needling into the skin that the device mimics. The needles were fixed with a plastic ring and micropore on the body of the participants without manipulation.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham control group II
Description: The acupuncturist disinfected the skin of the selected acupoints with alcohol, then vertically penetrated the skin with disposable stainless-steel needles (size, brand, Taiwan) to the depth predetermined for each point (between 8-25 mm, depending on the location of the acupoint) and achieved a deqi response, often described as a pressure, fullness, or achiness feeling around the acupoints.
Study: NCT05924438

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Delstrigo
Description: Treatment Group 1 Participants will receive Doravirine, as part of a fixed-dose oral combination with lamivudine and tenofovir disoproxil fumarate (DOR/3TC/TDF, Delstrigo)tablets which are to be administered orally and once daily.

Intervention type: DRUG
Group type: OTHER
Intervention: KOCITAF
Description: Treatment Group 2 Participants will receive dolutegravir, as part of a fixed-dose oral combination with tenofovir alafenamide plus emtricitabine (DTG/TAF/FTC, KOCITAF) tablets which are to be administered orally and once daily.
Study: NCT04689425

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Umbilical cord blood mononuclear cell gel（MNC）
Description: Local wound treatment by combination of PRP and MNC, once;

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: The platelet rich plasma（PRP）
Description: Local wound treatment by PRP alone, once.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: The platelet rich plasma（PRP）
Description: Local wound treatment by PRP alone, once.
Study: NCT06285929

Intervention type: OTHER
Intervention: ACS CARES Student Navigation
Description: Student volunteers providing navigation support to patients, families and caregivers with a cancer diagnosis through an SDOH assessment.

Intervention type: OTHER
Intervention: ACS CARES Student Navigation
Description: Student volunteers providing navigation support to patients, families and caregivers with a cancer diagnosis through an SDOH assessment.
Study: NCT05906199

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Renexin CR 200/160mg
Description: Single oral administration of Renexin CR 200/160mg, QD

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Aspirin 100mg
Description: Single oral administration of Aspirin 100mg, QD
Study: NCT05424718

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MyPEEPS Mobile
Description: Mobile technology to deliver HIV prevention information specifically developed for at-risk young men that have sex with men (YMSM).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MyPEEPS Mobile
Description: Mobile technology to deliver HIV prevention information specifically developed for at-risk young men that have sex with men (YMSM).
Study: NCT05281926

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Poly ICLC
Description: IT Poly-ICLC injection (1.0 mg) at Day 1 of weeks 0, 1 and 2. IM Poly-ICLC (20 μg/Kg) at Day 1 and Day 3 of weeks 3, 4, 5 and 6.
Study: NCT05580952

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve replacement
Description: Transcatheter aortic valve replacement system
Study: NCT05436704

Intervention type: PROCEDURE
Intervention: EUS-FNB
Description: EUS-FNB
Study: NCT05802199

Intervention type: DIAGNOSTIC_TEST
Intervention: Hepatic fat fraction and hepatic fibrosis
Description: All patients underwent measurement of UDFF for hepatic fat fraction and auto-pSWE for hepatic fibrosis.~All patients underwent measurement of MRI-PDFF for hepatic fat fraction and MRE for hepatic fibrosis as reference standard.

Intervention type: DIAGNOSTIC_TEST
Intervention: Hepatic fat fraction and hepatic fibrosis
Description: All patients underwent measurement of UDFF for hepatic fat fraction and auto-pSWE for hepatic fibrosis.~All patients underwent measurement of MRI-PDFF for hepatic fat fraction and MRE for hepatic fibrosis as reference standard.
Study: NCT05965102

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tirelizumab；Chemotherapy monotherapy
Description: Tirelizumab combined with chemotherapy in first-line treatment of relapsed/metastatic non-small cell lung cancer with ECOG PS score of 2
Study: NCT05077423

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CD33*CD3 BsAb
Description: CD33xCD3 is a bispecific monoclonal antibody, which specifically targets CD33 on the AML blasts and CD3 on the T cells
Study: NCT06245031

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sensory Stimulation System (GS120) - Active
Description: Sensory Stimulation System (GS120) - Active settings
Study: NCT04614558

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Isatuximab
Description: Isatuximab in IV form (10mg/kg q weekly x 4 doses followed by 10mg/kg q 2 weeks) for a total of 6 month duration. Doses should be initiated at 175 mg/hour up to a maximum of 400 mg/hour.~Isatuximab (SAR) is monoclonal antibody (mAb).
Study: NCT05559346

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diaphragmatic exercises
Description: Diaphragm exercises will be applied to the research group in addition to conventional rehabilitation.The content of the individualized conventional rehabilitation program consists of passive stretching exercises, strengthening exercises to antagonists of spastic muscles and exercises aimed at improving weight transfer, balance and correction reactions, and postural control. In addition to conventional rehabilitation, manual diaphragmatic relaxation exercises and diaphragmatic breathing exercises will be applied to the children in the research group two days a week.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conventional physiotherapy
Description: The control group will only be taken to the conventional rehabilitation program. e content of the individualized conventional rehabilitation program consists of passive stretching exercises, strengthening exercises to antagonists of spastic muscles and exercises aimed at improving weight transfer, balance and correction reactions, and postural control.
Study: NCT05921708

Intervention type: OTHER
Intervention: Assessment1
Description: International Physical Activity Questionnaire (IPAQ) (Short)

Intervention type: OTHER
Intervention: Assessment1
Description: International Physical Activity Questionnaire (IPAQ) (Short)

Intervention type: OTHER
Intervention: Assessment1
Description: International Physical Activity Questionnaire (IPAQ) (Short)

Intervention type: OTHER
Intervention: Assesment2
Description: Physical Appearance Comparison Scale-Revised (PACS-R)

Intervention type: OTHER
Intervention: Assesment2
Description: Physical Appearance Comparison Scale-Revised (PACS-R)

Intervention type: OTHER
Intervention: Assesment2
Description: Physical Appearance Comparison Scale-Revised (PACS-R)

Intervention type: OTHER
Intervention: Assessment3
Description: Sociocultural Attitudes Towards Appearance Questionnaire -4-Revised (SATAQ-4R)

Intervention type: OTHER
Intervention: Assessment3
Description: Sociocultural Attitudes Towards Appearance Questionnaire -4-Revised (SATAQ-4R)

Intervention type: OTHER
Intervention: Assessment3
Description: Sociocultural Attitudes Towards Appearance Questionnaire -4-Revised (SATAQ-4R)

Intervention type: OTHER
Intervention: Assessment4
Description: Body-Cathexis Scale (BCS)

Intervention type: OTHER
Intervention: Assessment4
Description: Body-Cathexis Scale (BCS)

Intervention type: OTHER
Intervention: Assessment4
Description: Body-Cathexis Scale (BCS)

Intervention type: OTHER
Intervention: Assessment5
Description: Mobile Health, Exercise Preferences and Social Media Questionnaire

Intervention type: OTHER
Intervention: Assessment5
Description: Mobile Health, Exercise Preferences and Social Media Questionnaire

Intervention type: OTHER
Intervention: Assessment5
Description: Mobile Health, Exercise Preferences and Social Media Questionnaire
Study: NCT05540457

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intermittent Non-InvasiveBlood Pressure Monitor
Description: Brachial cuff integrated with theTablo Hemodialysis System. Cuffwill be placed contralateral to theaccess arm, with measurementscollected pre-dialysis, every 30minutes during dialysis, and post-dialysis.~Device: Continuous Non-InvasiveBlood Pressure Monitor VitalStream Monitor. Finger cuffwill be placed ipsilateral to theaccess arm, with measurementscollected pre-dialysis,continuously during dialysis, andpost-dialysis.
Study: NCT05654012

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Pressure pain thresholds (PPT)
Description: Pressure will be increased continually and participants will be instructed to press a button the first moment they feel pain from the pressure stimulus.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Pressure pain thresholds (PPT)
Description: Pressure will be increased continually and participants will be instructed to press a button the first moment they feel pain from the pressure stimulus.
Study: NCT04823208

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3437943
Description: Administered SC

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered SC
Study: NCT05654012

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Conditioned pain modulation (CPM) efficiency
Description: The CPM paradigm assesses endogenous inhibitory pain modulation efficiency related to spatial filtering of nociceptive information.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Conditioned pain modulation (CPM) efficiency
Description: The CPM paradigm assesses endogenous inhibitory pain modulation efficiency related to spatial filtering of nociceptive information.
Study: NCT05549544

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Left bundle branch area pacing
Description: Left bundle branch area pacing is a novel physiological pacing modality and is reported to be feasible and safe in patients with heart failure and left bundle branch block.
Study: NCT05632458

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Thrombectomy
Description: Thrombectomy using double stent retriever vs thrombectomy using single stent retriever.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Thrombectomy
Description: Thrombectomy using double stent retriever vs thrombectomy using single stent retriever.